Investment Rating - The report maintains an "Overweight" rating for the commercial aerospace sector [6]. Core Insights - SpaceX plans to deploy up to 1 million AI satellites to create the world's first space data center, expanding the demand for commercial aerospace [1][2]. - The new satellites will operate at altitudes of 500km, 1000km, and 2000km, providing large-scale AI inference and data center services to billions of users globally [1]. - The focus of competition in commercial aerospace is shifting from communication services to the development of orbital computing infrastructure [2]. Summary by Sections Satellite Deployment - SpaceX's initiative aims to establish a "space-based computing network" that leverages solar energy and the unique environment of space to handle high-intensity computing tasks, overcoming the limitations faced by terrestrial data centers [2]. Rocket Manufacturing and Launch Capabilities - SpaceX has reduced the cost of launching payloads to approximately $1400-$2000 per kilogram through the regular recovery and reuse of Falcon 9 rocket boosters, with plans to further decrease costs to $100 per kilogram with the next-generation fully reusable Starship [3]. Communication Infrastructure - Inter-satellite laser communication is critical for the SpaceX orbital data center system, facilitating all major data transmission and network routing tasks [4]. Strategic Asset Integration - Elon Musk is considering merging SpaceX with his AI company xAI or Tesla to enhance the space computing layout, potentially allowing SpaceX's orbital data centers to provide significant computing power to xAI [5]. Investment Recommendations - The report suggests focusing on companies in the rocket sector such as Chaojie Co., Gaohua Technology, and Zhongheng Design, as well as satellite companies like Shaanxi Huada, Shanghai Port, and others [5].

2026 年 2 月 2 日 公司研究 因内码调整进度偏慢拖累，预计 25H2 业绩承压 ——澳优（1717.HK）2025 年业绩前瞻 资料来源：Wind，光大证券研究所预测，股价时间为 2026-01-30 （注：汇率为 1 港币=0.8926 元人民币，23-27 年股本 数分别为 17.80/17.80/17.78/17.78/17.78 亿股） 要点 2025 年业绩前瞻：1）我们预计公司 25 年收入同比增长 1.1%，收入增速较 25H1 放缓主要受国内奶粉业务拖累。2）我们预计公司 25 年归母净利润同比基本持 平；25H2 利润同比下滑主要系内码调整进度低于预期，以及行业竞争加剧，导 致高毛利率的国内奶粉业务收入占比下降。 内部调整滞后、外部行业环境恶化等因素影响，25 年业绩预计不及预期。 1）内码切换进度滞后：25 年 4 月公司启动内码切换工作并同步涨价，消费者提 前囤货，使得内码切换完成时间从三季度延迟至四季度，打乱了下半年核心业务 的增长节奏。2）行业竞争加剧：25 年行业内多家企业推出补贴或降价策略，而 公司此时处于涨价阶段，在价格竞争中处于被动地位。3）行业收入增速下滑： 25 ...

2026 年 2 月 2 日 晨会速递 分析师点评 市场数据 总量研究 【宏观】开年经济成色几何？——2026 年 1 月 PMI 点评 1 月制造业、非制造业景气度均落入收缩区间，重点关注几点变化：一是，受天气转 冷、临近春节人员返乡以及年末需求提前释放等因素影响，经济活动呈现季节性放缓； 二是，海外备货旺季结束，出口景气度回落，装备制造业有所承压；三是，新旧动能 分化加大，高技术制造业持续扩张，消费品制造业景气度落入收缩区间；四是，原材 料价格涨幅明显快于产成品价格，对部分企业利润有所影响。 【宏观】沃什将如何重塑政策路径与市场预期？——解构美国系列第十八篇 1 月 30 日，特朗普提名凯文·沃什为新一届美联储主席。在政策观点上，其支持进一 步降息，但对美联储扩表持谨慎态度，绝非纯粹"鸽派"，美联储后续或呈现"降息 与缩表并行"的政策组合。从资产反应来看，市场更多交易其反对扩表的"鹰派"一 面，黄金与美股出现明显回调。我们认为，沃什上台后并不会快速推进缩表进程，节 奏上"降息在前，缩表在后"，当前市场无需对流动性过于"恐慌"。 【策略】关注业绩，持股过节——2026 年 2 月策略观点 我们认为，本轮春季 ...

Investment Rating - The report maintains a "Buy" rating for the public utility sector [6] Core Insights - The commercial model of the power sector is continuously transforming, with a reduced reliance on annual long-term contracts for electricity and prices. The sector is shifting towards mid-to-long-term markets, spot markets, and capacity markets, indicating a comprehensive push for marketization [19][3] - The capacity price mechanism is being refined, with the aim to optimize the electricity market and ensure fair compensation reflecting the contributions of different power plants to peak demand [15][3] - The report highlights the importance of capacity market development, with current subsidies in Gansu and Yunnan reaching 330 RMB/kW·year, which helps offset the decline in electricity prices [19][3] Summary by Sections Market Performance - The SW public utility sector index fell by 1.66% this week, ranking 16th among 31 SW sectors. In comparison, the CSI 300 index rose by 0.08%, while the Shanghai Composite Index and Shenzhen Component Index fell by 0.44% and 1.62%, respectively [33][33] - Within sub-sectors, thermal power decreased by 2.78%, hydropower increased by 0.3%, while solar and wind power fell by 4.53% and 2.49%, respectively [33][33] Price Updates - Domestic and imported thermal coal prices have rebounded slightly, with domestic Qinhuangdao port 5500 kcal thermal coal rising by 4 RMB/ton, remaining below 700 RMB/ton. Imported coal prices also saw a slight increase [12][12] - The average clearing price for electricity in Shanxi and Guangdong has significantly increased due to cold weather, while the monthly agent purchase electricity costs are trending upwards due to rising capacity prices and the entry of renewable energy into the settlement cycle [13][12] Key Events - The National Development and Reform Commission and the National Energy Administration issued a notice to improve the capacity price mechanism for power generation, which includes optimizing compensation for coal and gas power generation [3][15] - Recent policy changes include relaxing the annual long-term contract signing ratio for coal-fired power companies and the cancellation of time-of-use electricity pricing in multiple regions [3][15] Recommendations - The report suggests focusing on national thermal power operators such as Huaneng International and Guodian Power, which are expected to maintain stable cash dividends. The profitability of thermal power is anticipated to gradually detach from coal cost dependency, shifting towards multiple influencing factors [19][3] - For long-term stable investment needs, the report recommends attention to companies like Yangtze Power, State Power Investment Corporation, and China National Nuclear Power [19][3]

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The company is planning a major asset restructuring to acquire minority stakes in its subsidiary, Tef International, to enhance its overseas building materials business [6][8] - The overseas building materials segment has shown significant growth, with Tef International projected to contribute substantially to the company's net profit [8][10] - The restructuring is expected to solidify the company's position in the overseas market and improve operational synergies [10] Summary by Sections Company Overview - The company has a total share capital of 1.918 billion shares and a market capitalization of 33.927 billion yuan [1] - The stock price has fluctuated between 6.92 yuan and 17.89 yuan over the past year [1] Financial Performance - The company reported a significant increase in revenue and net profit, with Tef International achieving a revenue of 8.19 billion yuan and a net profit of 1.47 billion yuan in 2025 [8][10] - The overseas building materials business accounted for 46% of total revenue and 58% of gross profit in the first half of 2025, with a gross margin of 36.8% [8] Future Projections - The company forecasts a net profit of 1.569 billion yuan for 2025, with a growth rate of 55.89% compared to the previous year [12] - The projected revenue for 2025 is 16.032 billion yuan, reflecting a growth rate of 27.24% [12] Valuation Metrics - The report estimates a P/E ratio of 22 for 2025 and a P/B ratio of 2.7 [12][15] - The expected EPS for 2025 is 0.82 yuan, with a projected ROE of 12.39% [12][15]

2026 年 2 月 1 日 总量研究 警惕转债估值过高的风险 ——2026 年 2 月 1 日可转债观察 要点 1、警惕转债估值过高的风险 金融资产价格的中长期走势在很大程度上取决于其估值，估值越贵则下跌的概率 越大。可转债是其正股的衍生品，因此其价格的走势既取决于正股，也取决于其 相对于正股的估值，后者较可能是主导转债市场波动的决定性力量。 转股溢价率是最重要的估值指标之一。其代表转债价格相对于转换价值的溢价程 度，或者说是为了使转股不亏钱而需要的正股涨幅。在其他条件相同时，转股溢 价率越高则其估值越贵。 2026 年 1 月末，转债市场转股溢价率的中位数为 33.2%，处于自 2018 年初以 来的 71%分位数，估值已偏贵。进一步讲，只有 2022-2024 年中一些月份的转 股溢价率明显超过了 2026 年 1 月末，而这段时间溢价率的抬升主要是正股下跌 所导致的。（注：正股和转债同时下跌而转债跌幅小，因此溢价率抬升。） 为了过滤掉正股下跌的影响，我们剔除了每一时间点净价低于 120 元的转债， 重新计算转股溢价率中位数。2026 年 1 月末，净价在 120 元（含）以上的转债 的溢价率中位数为 ...

Investment Rating - The report maintains an "Overweight" rating for the copper industry [6] Core Viewpoints - The report is optimistic about the upward trend of copper prices in 2026, driven by tight supply and improving demand [4][10] - As of January 30, 2026, the SHFE copper closing price was 103,680 CNY/ton, up 2.31% from January 23, while the LME copper closing price was 13,071 USD/ton, down 0.44% [1][17] - The report highlights a decrease in domestic copper social inventory by 2.2% and an increase in LME copper inventory by 2.6% [2][25] Supply Summary - In January 2026, China's electrolytic copper production was 1.1793 million tons, a 0.1% increase month-on-month and a 16.3% increase year-on-year [3][65] - The TC spot price was -50.30 USD/ton, remaining at a low level since September 2007 [3][60] - Domestic copper concentrate inventory at major ports was 673,000 tons, down 6.8% from the previous week [2][46] Demand Summary - The cable industry's operating rate increased by 0.8 percentage points to 59.46% as of January 29, 2026 [4][74] - Air conditioning production for February to April 2026 is projected to decline by 31.6%, 6.5%, and increase by 4.0% year-on-year [4][92] - The report indicates that the cable sector accounts for approximately 31% of domestic copper demand [4] Investment Recommendations - The report recommends investing in Zijin Mining, Western Mining, Luoyang Molybdenum, and Jincheng Mining, while also paying attention to Tongling Nonferrous Metals [4]

Group 1 - The A-share market showed a significant upward trend in January 2026, with major indices rising, particularly the Sci-Tech 50 and CSI 500, while the Shanghai Composite Index increased by 3.8% [5][10] - Market trading volume increased significantly, with a record high of 3.99 trillion yuan on January 14, 2026, reflecting a recovery in investor sentiment [10][18] - The performance of various sectors was mixed, with non-ferrous metals and media leading gains, while banking and home appliances lagged behind [15][18] Group 2 - The report suggests maintaining a "growth + value" strategy in the Hong Kong stock market, as the overall trend is positive due to earnings recovery, improved liquidity, and low valuations [3][4] - The report emphasizes that small-cap stocks typically outperform during the spring market, driven by increased risk appetite and the influx of retail investors [71][88] - Key sectors to focus on include electronics, power equipment, machinery, non-ferrous metals, and communications, which are expected to perform well in February 2026 [3][4][73] Group 3 - The spring market is anticipated to be characterized by a focus on growth and cyclical sectors, with historical data indicating that these sectors often perform well during this period [73][88] - The report highlights that the consumer sector may receive policy support, as the government emphasizes domestic demand and market expansion [88][89] - Earnings forecasts for 2025 show improvement across various industries, particularly in non-ferrous metals, steel, and media, indicating a positive outlook for these sectors [61][81]

Investment Rating - The report maintains a rating of "Buy" for the pharmaceutical and biotechnology sector [5]. Core Insights - The report emphasizes the continuous focus on investment opportunities related to AI in healthcare, driven by the growth of Tencent's AI applications and the need for data-driven solutions in medical settings [2][21]. - The investment logic centers around "data closed-loop" and "scene demand," highlighting AI's role as a core productivity driver in healthcare under the dual pressures of cost control and technological advancements [22]. - The report outlines a three-stage clinical value investment strategy, focusing on innovative drug chains and medical devices, with specific recommendations for companies in these sectors [3][27]. Summary by Sections Market Review - Last week, the A-share pharmaceutical and biotechnology index fell by 3.31%, underperforming the CSI 300 index by 3.39 percentage points and ranking 22nd among 31 sub-industries [1][15]. - The Hong Kong Hang Seng Medical Health Index also declined by 2.98%, lagging behind the Hang Seng Index by 4.69 percentage points [1][15]. R&D Progress - Recent developments include new drug applications from companies such as Hengrui Medicine and Innovent Biologics, with ongoing clinical trials for various products [30]. Key Companies and Valuation - The report provides a detailed earnings forecast and valuation table for key companies, recommending "Buy" for several firms including Innovent Biologics, WuXi AppTec, and Mindray Medical [4][27]. AI Healthcare Investment Focus - The report identifies several core areas for AI in healthcare, including AI drug development, medical imaging, chronic disease management, and surgical robotics, emphasizing the importance of proprietary data and business scenarios for competitive advantage [22][24]. Annual Investment Strategy - The report suggests that the investment focus should increasingly emphasize the clinical value of pharmaceuticals, with a positive outlook on innovative drug chains and high-end medical devices [3][26].

2026 年 2 月 1 日 电力设备新能源、环保 《关于完善发电侧容量电价机制的通知》出台 ——电新环保行业周报 20260201 电力设备新能源 买入（维持） 环保 买入（维持） 作者 分析师：殷中枢 执业证书编号：S0930518040004 010-58452071 yinzs@ebscn.com 分析师：郝骞 执业证书编号：S0930520050001 021-52523827 haoqian@ebscn.com 分析师：陈无忌 执业证书编号：S0930522070001 021-52523693 chenwuji@ebscn.com 分析师：和霖 执业证书编号：S0930523070006 021-52523853 helin@ebscn.com 分析师：邓怡亮 执业证书编号：S0930525070003 021-52523802 dengyiliang@ebscn.com 行业与沪深 300 指数对比图 -20% 0% 20% 40% 60% 80% 2025/1/30 2025/6/1 2025/10/1 2026/1/31 电力设备(申万) 环保(申万) 沪深300 资料来源：iFinD 要 ...